Search

Search Constraints

You searched for: Author/Creator Shapira-Frommer, R.

Search Results

1. 2746 A Phase 2 open-label, multicenter study of single-agent rucaparib in the treatment of patients with relapsed ovarian cancer and a deleterious BRCA mutation. (September 2015)

2. 523 Initial clinical experience with pembrolizumab in metastatic heavily pre-treated patients with solid cancers in a single institution. (September 2015)

3. Integrated efficacy and safety analysis of the poly(ADP-ribose) polymerase (PARP) inhibitor rucaparib in patients (pts) with high-grade ovarian carcinoma (HGOC). (February 2017)

4. Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer Immunotherapy. (25th November 2015)